NEUROPEPTIDES AND NASAL SECRETION

被引:62
作者
BARANIUK, JN
KALINER, M
机构
[1] NIAID, CLIN INVEST LAB, ALLERG DIS SECT, BETHESDA, MD 20892 USA
[2] NATL HEART & LUNG INST, DEPT THORAC MED, LONDON SW3 6LY, ENGLAND
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1991年 / 261卷 / 04期
关键词
SUBSTANCE-P; NEUROKININ-A; TACHYKININS; CALCITONIN GENE-RELATED PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE; NEUROPEPTIDE-Y; MUCUS SECRETION; VASCULAR PERMEABILITY;
D O I
10.1152/ajplung.1991.261.4.L223
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The nasal mucosa is innervated by the sensory, parasympathetic, and sympathetic nervous systems. Nociceptive sensory nerves are stimulated by mucosal injury, inhalation of irritants, or mast cell degranulation and release of the calcitonin gene-related peptide, the tachykinins substance P and neurokinin A, and other peptides by the axon response mechanism. Sensory nerve stimulation initiates systemic reflexes, such as the sneeze, and central parasympathetic reflexes which release acetylcholine, vasoactive intestinal peptide, and other peptides and lead to glandular secretion. In concert, these proinflammatory neural responses lead to vasodilation, vascular permeability, and glandular secretion. Sympathetic nerves release neuropeptide Y and norepinephrine, potent vasoconstrictors which act to decompress the nasal mucosa and produce nasal patency. The balance between the effects of parasympathetic and sympathetic neurotransmitters may regulate nasal homoeostasis, whereas the nociceptive sensory system may be held in reserve as a defense mechanism. Dysfunction of these systems may lead to pathological nasal syndromes. In the future, specific neuropeptide agonists and antagonists may be useful for the treatment of human rhinitic diseases.
引用
收藏
页码:L223 / L235
页数:13
相关论文
共 50 条
[21]   TRPV1 Mediates Glucose-induced Insulin Secretion Through Releasing Neuropeptides [J].
Zhong, Beihua ;
Ma, Shuangtao ;
Wang, Donna H. .
IN VIVO, 2019, 33 (05) :1431-1437
[22]   Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets [J].
Kawamura, N ;
Tamura, H ;
Obana, S ;
Wenner, M ;
Ishikawa, T ;
Nakata, A ;
Yamamoto, H .
NEUROIMMUNOMODULATION, 1998, 5 (1-2) :9-15
[23]   IMMUNOREACTIVE NEUROPEPTIDES IN THE CELLS OF HUMAN THYMUS [J].
Leposavic, Gordana ;
Todorovic, Vera ;
Nikolic, I. ;
Perisic, Milica .
ARCHIVES OF BIOLOGICAL SCIENCES, 2011, 63 (04) :971-977
[24]   REINNERVATION AND NEUROPEPTIDES IN MOUSE SKIN FLAPS [J].
KARANTH, SS ;
DHITAL, S ;
SPRINGALL, DR ;
POLAK, JM .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1990, 31 (02) :127-134
[25]   Effects of Neuropeptides on Dendritic Cells in the of Psoriasis [J].
Zhang, Jingya ;
Zhao, Siqi ;
Xing, Xinzhu ;
Shang, Lin ;
Cao, Jiali ;
He, Yanling .
JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 :35-43
[26]   Neuropeptides and their interaction with exercise and immune function [J].
Jonsdottir, IH .
IMMUNOLOGY AND CELL BIOLOGY, 2000, 78 (05) :562-570
[27]   EXTRACTION AND QUANTITATION OF NEUROPEPTIDES IN BONE BY RADIOIMMUNOASSAY [J].
AHMED, M ;
SRINIVASAN, GR ;
THEODORSSON, E ;
BJURHOLM, A ;
KREICBERGS, A .
REGULATORY PEPTIDES, 1994, 51 (03) :179-188
[28]   Mediator release of neuropeptides after nasal provocation in perennial allergic rhinitis patients [J].
Gawliki, Radoslaw ;
DuBuske, Lawrence .
RHINOLOGY, 2010, 48 (02) :206-210
[29]   LOW PLASMA-CONCENTRATIONS OF VIP AND ELEVATED LEVELS OF OTHER NEUROPEPTIDES DURING EXACERBATIONS OF ASTHMA [J].
CARDELL, LO ;
UDDMAN, R ;
EDVINSSON, L .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (12) :2169-2173
[30]   Species differences in the actions of sensory neuropeptides on contractility of the smooth muscle of the rat and guinea-pig prostate [J].
Ventura, S ;
Lau, WAK ;
Buljubasich, S ;
Pennefather, JN .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (11) :917-921